2023 Annual Meeting | C176 - Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia
03:30 PM - 03:55 PM EST | Speaker |
AChR+Ve Myasthenia Gravis
Srikanth Muppidi, MD, FAAN |
03:55 PM - 04:15 PM EST | Speaker |
Ocular and MuSK Myasthenia Gravis
Neelam Goyal, MD |
04:15 PM - 04:35 PM EST | Speaker |
Complement Inhibition in Myasthenia Gravis
Srikanth Muppidi, MD, FAAN |
04:35 PM - 04:55 PM EST | Speaker |
FcRn Inhibition in Myasthenia Gravis
Neelam Goyal, MD |
04:55 PM - 05:30 PM EST | Speaker |
Challenging Cases from Clinical Practice
Srikanth Muppidi, MD, FAAN, Neelam Goyal, MD |
Srikanth Muppidi, MD, FAAN | Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. muppidi has received publishing royalties from a publication relating to health care. |
Neelam Goyal, MD | Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx. |